Cargando…
Development and Validation of an IL6/JAK/STAT3-Related Gene Signature to Predict Overall Survival in Clear Cell Renal Cell Carcinoma
Background: Traditional clinicopathological features (TNM, pathology grade) are often insufficient in predictive prognosis accuracy of clear cell renal cell carcinoma (ccRCC). The IL6-JAK-STAT3 pathway is aberrantly hyperactivated in many cancer types, and such hyperactivation is generally associate...
Autores principales: | Zhan, Chuanchuan, Xu, Chao, Chen, Jiajun, Shen, Chong, Li, Jinkun, Wang, Zichu, Ying, Xiangrong, Luo, Zhengang, Ren, Yu, Wu, Gangfeng, Zhang, Haojie, Qian, Manfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511427/ https://www.ncbi.nlm.nih.gov/pubmed/34660570 http://dx.doi.org/10.3389/fcell.2021.686907 |
Ejemplares similares
-
Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma
por: Zhan, Chuanchuan, et al.
Publicado: (2021) -
Cuprotosis-related signature predicts overall survival in clear cell renal cell carcinoma
por: Zhang, Fan, et al.
Publicado: (2022) -
JAK-STAT in Early Hematopoiesis and Leukemia
por: Fasouli, Eirini Sofia, et al.
Publicado: (2021) -
JAK/STAT signaling in diabetic kidney disease
por: Liu, Yingjun, et al.
Publicado: (2023) -
Opposing JAK-STAT and Wnt signaling gradients define a stem cell domain by regulating differentiation at two borders
por: Melamed, David, et al.
Publicado: (2020)